Thanks to the rapid growth in Asia, flow control and treatment revenues in the municipal wastewater treatment sector will grow to over $23 billion in 2014. This is the latest aggregation from a number of market reports published by the ...
The Agency for Science, Technology and Research (A*STAR)'s Experimental Therapeutics Centre (ETC) and Swiss biopharmaceutical firm Debiopharm Group (Debiopharm) have signed an exclusive research collaboration to develop oral small molecules ...
Tags: Cancer Drugs, Medicine
Japanese pharmaceutical firm PeptiDream and France-based Ipsen have expanded their research collaboration and license option agreement signed in April 2013 to develop peptide drugs to treat serious endocrinologic disease. The deal has now ...
Tags: PeptiDream, Ipsen, peptide drugs
Hair color producer eSalon has selected Fusion Packaging to develop a new packaging for its hair oil brand, Shining Armor Renewing Treatment Oil. eSalon's new hair oil product will be offered in a 50ml airless simple and sleek white ...
Tags: Fusion, Esalon's Hair Oil
Shanghai MicroPort EP MedTech, a wholly-owned subsidiary of Shanghai MicroPort Medical Group, has obtained CE Mark approval for its Columbus 3D EP navigation system, indicated for the diagnosis and treatment of complex arrhythmia diseases. ...
SuperSonic Imagine, a medical ultrasound company, announced its Aixplorer MultiWave ultrasound system has obtained the US Food and Drug Administration (FDA) approval for the quantification capabilities of its real-time ShearWave ...
Tags: SuperSonic Imagine, Medicine
US-based Intact Vascular has completed the patient enrollment in the Tack Optimized Balloon Angioplasty (TOBA) study, a multi-center study designed to collect confirmatory data on the use of Tack-It Endovascular System in the superficial ...
Tags: Medicine, Patient Enrollment
Mystic Pharmaceuticals has received notices of allowance from the China Patent Office and the Japan Patent Office for its 'Deep Draw Container Forming Method' and 'Combination Unit Dose Dispensing Container' patent applications ...
Tags: Drug Delivery Platforms, Medicine
US-based biopharmaceutical company Galena Biopharma has launched the Abstral (fentanyl) sublingual tablets in the US for the treatment of breakthrough cancer pain. The sublingual (under the tongue) fentanyl tablet has been designed for ...
Tags: Sublingual Tablets, Medicine
Israel-based oral drug delivery systems developer Oramed Pharmaceuticals has received two additional patent approvals in Japan and Canada for its platform protein oral delivery (POD) technology. The two patents are entitled 'Methods and ...
Tags: Pod Technology, Oramed
Nucletron, an Elekta Company, has obtained 510(k) approval from the US Food and Drug Administration (FDA) for Esteya electronic brachytherapy system, a new approach for high precision skin cancer treatment. Depending on a small, high dose ...
Cornerstone Pharmaceuticals has received the US Food and Drug Administration (FDA) orphan drug designation for its altered energy metabolism directed (AEMD) drug candidate 'CPI-613' for treatment of myelodysplastic syndrome (MDS). MDS is ...
Japanese pharmaceutical firm Eisai has secured approval from the European Commission (EC) on the license extension application for the use of antiepileptic agent Zonegran (zonisamide) in the treatment of pediatric patients. The EC ...
Tags: Eisai Obtains, Zonegran
The US Food and Drug Administration (FDA) has approved US-based StemCells’ investigational new drug (IND) application for clinical testing of its HuCNS-SC human neural stem cells as a treatment for spinal cord injury. StemCells is ...
Tags: Spinal Cord Injury, Medicine
Canadian regulatory authority Health Canada has approved Valeant Pharmaceuticals International subsidiary Valeant Canada's new drug submission of Jublia for the treatment of onychomycosis. Jublia is designated for the treatment of mild to ...
Tags: Fungal Drug, Medicine